𝔖 Bobbio Scriptorium

✦ LIBER ✦

Food and Drug Administration (FDA) drug approval end points for chronic cutaneous ulcer studies

✍ Scribed by Eaglstein, William H.; Kirsner, Robert S.; Robson, Martin C.

Book ID: 119854891
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 84 KB
Volume: 20
Category: Article
ISSN: 1067-1927
DOI: 10.1111/j.1524-475x.2012.00849.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1222 Pharmacotherapy for Inflammatory

Sa1222 Pharmacotherapy for Inflammatory Disorders and the Risk for Invasive Parasitic Infections: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS) From the REFURBISH Study

✍ Parakkal Deepak; Derrick J. Stobaugh; Eli D. Ehrenpreis 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Results of the Post-U.S. Food and Drug A

Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation: A Prospective Study Using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support)

✍ Randall C. Starling; Yoshifumi Naka; Andrew J. Boyle; Gonzalo Gonzalez-Stawinski 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 905 KB